Peripheral T lymphocytes CD4+ and CD8+ play a key part in anti-tumor immunity, and CD4+ T cells help in recruiting CD8+ T cells, while CD8+ T cells directly attack and kill tumor cells. Here, CD8A is linked to neoplasm.